Skip to main content
BDSX
NASDAQ Industrial Applications And Services

10% Owner Jack Schuler Buys 100,000 Biodesix Shares for $1.0M After Guidance Cut

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$10.12
Mkt Cap
$112.216M
52W Low
$5.26
52W High
$31.97
52W Position info
92% above low
Off High info
68% below high
Rel. Volume info
3.6× avg
Market data snapshot near publication time

BDSX sits 92% above its 52-week low of $5.26 on elevated volume (3.6× avg).

Summary

Biodesix 10% owner and Emeritus Director Jack W. Schuler bought 100,000 shares at a weighted average of $10.0199, about $1.0 million, two days after the company's Q3 revenue miss and guidance cut.


Key Events · Ownership and Investor Activity · BDSX

  • 10% Owner Buys $1.0M of Stock

    On 2026-11-10, Jack W. Schuler acquired 100,000 shares at a weighted average price of $10.0199 for a total of $1,001,990, through the Jack W. Schuler Living Trust.

  • Purchase Follows Guidance Cut

    The buy came two days after Biodesix reported Q3 revenue of $24.0 million, about 13% below the $27.5 million estimate, and cut full-year 2026 revenue guidance.

  • Holdings After the Buy

    Post-transaction, the trust holds 655,810 shares, and Schuler separately holds 1,800,000 shares through the Jack W. Schuler 2026 GRAT.

  • Price Range of Purchases

    Per the filing footnote, shares were bought in multiple transactions at prices from $9.655 to $10.25.


Analysis · BDSX · Industrial Applications And Services

Two trading days after Biodesix cut full-year 2026 revenue guidance and the stock fell sharply, Schuler put about $1.0 million of real money into the open market. For a micro-cap, the purchase is roughly 0.9% of the company's market value—large enough to matter. It comes from a long-standing large holder rather than an operating executive, so it reads as a vote of confidence in the price rather than a change in the business outlook. The weighted average price of $10.0199 is below today's $10.12, consistent with buying into post-selloff weakness.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BDSX was trading at $10.12 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $112.2M. The 52-week trading range was $5.26 to $31.97. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BDSX - Latest Insights

BDSX
Nov 12, 2026, 9:29 AM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $10.12
Real-time Price: $10.17 info
Change: +$0.050 (+0.49%) info
Market Cap: $112.77M info
BDSX
Nov 06, 2026, 3:24 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $11.61
Real-time Price: $10.17 info
Change: -$1.44 (-12%) info
Market Cap: $112.77M info
BDSX
Nov 05, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $16.00
Real-time Price: $10.17 info
Change: -$5.83 (-36%) info
Market Cap: $112.77M info
BDSX
Nov 05, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.70
Real-time Price: $10.17 info
Change: -$8.53 (-46%) info
Market Cap: $112.77M info
BDSX
Nov 05, 2026, 4:02 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $18.70
Real-time Price: $10.17 info
Change: -$8.53 (-46%) info
Market Cap: $112.77M info